Elizabeth Schneider: Revolutionary Drug Shows Promise for Primary Ovarian Insufficiency
Elizabeth Schneider, Staff Product Marketing Manager at Illumina, shared a post on LinkedIn:
“Primary ovarian insufficiency (POI), in which the ovaries don’t mature and release eggs properly, affects about 3% of women under age 40 and typically causes infertility. But a drug already approved to treat kidney disease may one day help some of these people get pregnant, a research team reports today in Science.
In studies of mouse ovarian tissue and live mice, the drug, called finerenone, kick-started the growth of tiny egg-containing sacs, or follicles—a process that’s often defunct in people with POI. In a small clinical trial, people with POI who were given the drug went on to produce mature eggs that could be harvested, and some of the eggs were then successfully fertilized in the lab.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 21, 2026, 17:57Ula Sankowska: What I’ll Bring to ASRM INNOVATE in Baltimore
-
Oct 21, 2026, 17:40Robert Borowczyk: The Invisible Waiting Room
-
Oct 21, 2026, 17:35Fereshteh Safian: Behind the Scenes of Reproductive Medicine
-
Oct 21, 2026, 17:20The Relationship Between Trophectoderm Biopsy and Early Pregnancy Outcomes – RBMO
-
Oct 21, 2026, 17:09Jules McDonald: The Future of Fertility Is Happening in Abu Dhabi
-
Oct 21, 2026, 16:53Ashley Evans: I Never Imagined I’d Be a Fertility Story with a Group of People Whom I Have Never Met…
-
Oct 21, 2026, 16:41Karthik Raj: Asherman’s Syndrome – When the Endometrium Cannot Regenerate Normally
-
Oct 21, 2026, 16:36Katy Encalade: A Few Misconceptions I Think Every Woman Considering Egg Donation Deserves to Understand
-
Oct 21, 2026, 16:21The FeRGI Working Group 2026-2027 – ESHRE SIG Reproductive Genetics